BioDelivery Sciences International (NASDAQ:BDSI), Arrowhead Research Corporation (NASDAQ:ARWR) and NanoString Technologies Inc. (NASDAQ:NSTG) are the market’s top performers today. The companies that struggled most are Gigamon Inc (NYSE:GIMO), Federal Home Loan Mortgage Corp. (OCTBB:FMCCS) and Lumber Liquidators Holdings Inc. (NYSE:LL).
BioDelivery Sciences International Climbs
There's a gold rush coming as electric vehicle manufacturers fight for market share, proclaimed David Einhorn at this year's 2021 Sohn Investment Conference. Check out our coverage of the 2021 Sohn Investment Conference here. Q1 2021 hedge fund letters, conferences and more SORRY! This content is exclusively for paying members. SIGN UP HERE If you Read More
BioDelivery Sciences International climbed +8.48% today. The development-stage biotech company, a Julian Robertson pick, has climbed +16.07% over the past five days and an impressive +136.67% in 2014. On Monday, BDSI announced positive results in one of its trials.
The price of Arrowhead Research surged +8.07%, thanks in large part to comments made today on CNBC’s Fast Money. A new Q1 buy for billionaire investor George Soros, the biopharmaceutical firm has rallied +516% over the past year.
Another new Soros buy, NanoString Technologies Inc., jumped +7.1%. Despite today’s surge, the stock is down -23.9% in 2014.
Gigamon Takes a Major Dive Following Preliminary Q1 Results
Gigamon Inc (NYSE:GIMO) is the day’s biggest loser, as its price took a major dive, falling -32.4% today. A first quarter buy for both Julian Robertson and George Soros, Gigamon plummeted after reporting preliminary Q2 results. Goldman Sachs analysts downgraded it from buy to neutral as well, lowering its target price to $14 from $29. Gigamon’s share price has declined -56.23% in 2014.
Federal Home Loan Mortgage Corp. declined -9.03%, taking the second spot on today’s list of losers. And the third spot goes to Lumber Liquidators Holdings Inc., the price of which dipped -8.06%. The hardwood flooring retailer slashed its 2014 outlook today, butting its earnings outlook to $2.65 to $3.00 per share on revenue of $1.05 billion to $1.10 billion.